Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipidem versus Lipofundin MCT in adults on home parenteral nutrition with chronic intestinal failure
NL-OMON55393Phase 4Active, not recruiting
- Sponsor
- B. Braun
- Start
- Jan 2018
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in intestinal failure (IF) comparing Lipidem with Lipofundin MCT (2 arms). Started Jan 2018; status: active, not recruiting.
02
Drugs
Lipidemmedium-chain triglycerides + long-chain triglycerides
03
Conditions
intestinal failure (IF)
Beyond the preview
Go deeper on NL-OMON55393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55393.